Literature DB >> 17589543

Life and death in peripheral T cells.

Peter H Krammer1, Rüdiger Arnold, Inna N Lavrik.   

Abstract

During the course of an immune response, antigen-reactive T cells clonally expand and then are removed by apoptosis to maintain immune homeostasis. Life and death of T cells is determined by multiple factors, such as T-cell receptor triggering, co-stimulation or cytokine signalling, and by molecules, such as caspase-8 (FLICE)-like inhibitory protein (FLIP) and haematopoietic progenitor kinase 1 (HPK1), which regulate the nuclear factor-kappaB (NF-kappaB) pathway. Here, we discuss the concepts of activation-induced cell death (AICD) and activated cell-autonomous death (ACAD) in the regulation of life and death in T cells.

Entities:  

Mesh:

Year:  2007        PMID: 17589543     DOI: 10.1038/nri2115

Source DB:  PubMed          Journal:  Nat Rev Immunol        ISSN: 1474-1733            Impact factor:   53.106


  245 in total

Review 1.  Regulation of CD95/Fas signaling at the DISC.

Authors:  I N Lavrik; P H Krammer
Journal:  Cell Death Differ       Date:  2011-11-11       Impact factor: 15.828

Review 2.  T-cell activation and transplantation tolerance.

Authors:  Bhavana Priyadharshini; Dale L Greiner; Michael A Brehm
Journal:  Transplant Rev (Orlando)       Date:  2011-11-08       Impact factor: 3.943

3.  Inflammatory cytokines determine the susceptibility of human CD8 T cells to Fas-mediated activation-induced cell death through modulation of FasL and c-FLIP(S) expression.

Authors:  Anna von Rossum; Randall Krall; Nichole K Escalante; Jonathan C Choy
Journal:  J Biol Chem       Date:  2011-04-25       Impact factor: 5.157

4.  Up-regulation of fas and fasL pro-apoptotic genes expression in type 1 diabetes patients after autologous haematopoietic stem cell transplantation.

Authors:  G L V de Oliveira; K C R Malmegrim; A F Ferreira; R Tognon; S Kashima; C E B Couri; D T Covas; J C Voltarelli; F A de Castro
Journal:  Clin Exp Immunol       Date:  2012-06       Impact factor: 4.330

5.  Dead on arrival: understanding the failure of CTLA4-immunoglobulin therapy in inflammatory bowel disease.

Authors:  Lloyd Mayer; Arthur Kaser; Richard S Blumberg
Journal:  Gastroenterology       Date:  2012-05-21       Impact factor: 22.682

6.  FLIP: a novel regulator of macrophage differentiation and granulocyte homeostasis.

Authors:  Qi-Quan Huang; Harris Perlman; Zan Huang; Robert Birkett; Lixin Kan; Hemant Agrawal; Alexander Misharin; Sandeep Gurbuxani; John D Crispino; Richard M Pope
Journal:  Blood       Date:  2010-08-19       Impact factor: 22.113

Review 7.  Mitochondrial shape changes: orchestrating cell pathophysiology.

Authors:  Silvia Campello; Luca Scorrano
Journal:  EMBO Rep       Date:  2010-08-20       Impact factor: 8.807

8.  Modulation of CD4+ T-cell activation by CD95 co-stimulation.

Authors:  M Paulsen; S Valentin; B Mathew; S Adam-Klages; U Bertsch; I Lavrik; P H Krammer; D Kabelitz; O Janssen
Journal:  Cell Death Differ       Date:  2010-11-05       Impact factor: 15.828

9.  Development of chimeric antigen receptors targeting T-cell malignancies using two structurally different anti-CD5 antigen binding domains in NK and CRISPR-edited T cell lines.

Authors:  Sunil S Raikar; Lauren C Fleischer; Robert Moot; Andrew Fedanov; Na Yoon Paik; Kristopher A Knight; Christopher B Doering; H Trent Spencer
Journal:  Oncoimmunology       Date:  2017-12-26       Impact factor: 8.110

10.  The Nore1B/Mst1 complex restrains antigen receptor-induced proliferation of naïve T cells.

Authors:  Dawang Zhou; Benjamin D Medoff; Lanfen Chen; Lequn Li; Xian-feng Zhang; Maria Praskova; Matthew Liu; Aimee Landry; Richard S Blumberg; Vassiliki A Boussiotis; Ramnik Xavier; Joseph Avruch
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-10       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.